Literature Review

Does Amyloid Accumulation Cause Midlife Cognitive Decline?


 

References

Although vascular risk factors such as diabetes and hypertension “likely contribute to some of the cognitive impairments known to occur with normal aging, they do not fully overlap with the findings reported by Jack et al,” said Dr. DeCarli. Genetic differences such as gender and APOE ε4 status also may play a role.

Additional genetic and animal research may reveal specific cell types and cortical networks that change dramatically during the first 50 years of life. Understanding these early processes will help neurologists identify ways to maintain cognitive health and resist dementia. “Such work requires the necessary motivation found by seminal work, such as that of Jack et al, which tell us where and when to investigate these processes,” said Dr. DeCarli. “Establishing what is normal creates avenues for new research, increasing the likelihood of discovering novel therapeutics for late-life disease states, which is a laudable goal indeed,” he concluded.

Erik Greb

Pages

Recommended Reading

Dose-related increase in mortality with antipsychotics in dementia
MDedge Neurology
Multidomain Intervention May Improve Cognitive Function in People at Risk for Dementia
MDedge Neurology
Interventions Could Reduce the Impact of Genetic Risk for Alzheimer’s Disease
MDedge Neurology
Flutemetamol PET Measures β-Amyloid Levels Accurately
MDedge Neurology
Should Nonpharmacologic Approaches Be First-Line Treatments for Dementia?
MDedge Neurology
Potential link between pulse pressure and dementia onset found
MDedge Neurology
Alzheimer’s disease biomarkers have limited association with each other
MDedge Neurology
Sleep Stage Distribution Linked to Cognitive Decline
MDedge Neurology
Cognitive Decline in Alzheimer’s Varies by Age
MDedge Neurology
Cognitive Decline, APOE ε4 Status, and Sex
MDedge Neurology

Related Articles